Binding and Unbinding Pathways of Peptide Substrates on the SARS-CoV-2 3CL Protease.
Kei MoritsuguToru EkimotoMitsunori IkeguchiAkinori KideraPublished in: Journal of chemical information and modeling (2022)
Based on many crystal structures of ligand complexes, much study has been devoted to understanding the molecular recognition of SARS-CoV-2 3C-like protease (3CL pro ), a potent drug target for COVID-19. In this research, to extend this present static view, we examined the kinetic process of binding/unbinding of an eight-residue substrate peptide to/from 3CL pro by evaluating the path ensemble with the weighted ensemble simulation. The path ensemble showed the mechanism of how a highly flexible peptide folded into the bound form. At the early stage, the dominant motion was the diffusion on the protein surface showing a broad distribution, whose center was led into the cleft of the chymotrypsin fold. We observed a definite sequential formation of the hydrogen bonds at the later stage occurring in the cleft, initiated between Glu166 (3CL pro ) and P3_Val (peptide), followed by binding to the oxyanion hole and completed by the sequence-specific recognition at P1_Gln.
Keyphrases
- sars cov
- early stage
- anti inflammatory
- respiratory syndrome coronavirus
- coronavirus disease
- amino acid
- binding protein
- emergency department
- neural network
- magnetic resonance imaging
- squamous cell carcinoma
- magnetic resonance
- dna binding
- radiation therapy
- small molecule
- electronic health record
- lymph node
- sentinel lymph node
- protein protein
- contrast enhanced
- drug induced
- transition metal